Healthcare in Thoughts from the Centre
- Select a blog category
Payment reform for integrated care: The risks and rewards of reforming payment mechanisms in the NHS
By Jon White, Deloitte Consulting
The NHS Five Year Forward View, published in 2014, included proposals to develop five new models of care or ‘Vanguards’ to help transform and integrate health and social care services. Starting in 2015. NHS England allowed health systems the flexibility to introduce new payment mechanisms that would provide better incentives for local care models. Five years on, we have seen pockets of innovation such as the aligned incentive contract in Coastal West Sussex and the outcomes based contract in Greater Manchester. However, by the end of the vanguard phase of the new care models programme, in March 2018, instead of developing new contracts, most vanguards had used a consensus approach based on non-legal agreements between their partners.i
By Greg Reh, vice chairman, US and Global Life Sciences leader, Deloitte LLP
This week’s blog, by Greg Reh from the US firm, first appeared on the US Center for Health Solutions blog site. The blog features Greg’s commentary on the panel discussion from the Financial Times US Pharma and Biotech Summit about the changes needed to face coming innovations in manufacturing, pricing, and reimbursement of personalized therapies. These innovations include direct-to-payer models, mass customization, and valuation of gene therapies and one-time treatments, all of which present unique challenges to pharma companies’ current technology systems.
By Karen Taylor, Director, Centre for Health Solutions
Several weeks ago I participated in a panel discussion on inclusion and diversity in clinical trials. My research for the event and the discussion that ensued led me to conclude that while there have been some improvements, the pharma industry continues to struggle to recruit sufficient trial participants from important demographic groups, especially women, racial and ethnic minorities, and the elderly. As a result, the outcomes seen in clinical trials are likely to be unrepresentative of the patient outcomes in the real world.
By James Banham and Seb Zanker
This latest in our series of blogs on the challenges facing Integrated Care Systems (ICS), focuses on how some commissioners are embracing the proposed model of place-based, shared decision making described in the recent guidance from NHS England and NHS Improvement ‘Designing integrated care systems in England’1; and what steps they are taking to transition from transactional to more strategic activities.
Enabling Integrated Care Systems to improve health outcomes through robust population health analytics
By Jon White, Director, Public sector health analytics team
This blog is the third in our series of articles examining the challenges in establishing Integrated Care Systems (ICSs) and explores the critical role of population health analytics. Indeed, there is a growing realisation across the healthcare sector about the potential for data analytics to transform everything from strategic planning to clinical decision making. Today, data technology has already transformed many aspects of our lives with unprecedented access to information, connecting people and ideas in ways no-one would have predicted twenty years ago. We have all seen first hand how analytics has impacted other sectors such as retail and marketing and we are now entering a period of rapid innovation in the healthcare sector, with numerous opportunities to utilise data effectively. In this blog we are taking a pragmatic view of some of the things ICSs can do to work collaboratively and focus on improving population health outcomes.
By Cosima Pettinicchio, and Dr Eva de Brett, Deloitte MCS
Last month’s blog from our Deloitte healthcare practice provided an overview of the key challenges facing NHS and Local Authority organisations as they transition from Sustainability and Transformation Programmes (STPs) to Integrated Care Systems (ICSs); and gave a commitment to explore each of these challenges in more depth in a series of articles over the summer.1 This week’s blog explores the key building blocks of a comprehensive, target-oriented, Population Health Management (PHM) approach and outlines the ‘no-regrets’ decisions that system leaders need to consider when embarking on their transition to an ICS.
By Dr Francesca Properzi, PhD. Research Manager, Centre for Health Solutions
Innovation and new technologies are acknowledged as key enablers of the digital transformation of the NHS, however, today, healthcare lags behind most other service industries in the adoption of technologies to improve performance and the service user experience. This week we launched our latest report, ‘Closing the digital gap: Shaping the future of UK healthcare’ which highlights the opportunities and future potential of digital technologies to tackle some of healthcare’s most intractable challenges.1 We acknowledge the numerous policy initiatives aimed at establishing ‘a digital NHS’, however, we also highlight a growing divide between policy ambition and the reality of the experience on the front-line.
By Catherine Skilton, Partner Deloitte’s Public Sector Healthcare team
As the first half of the year draws to a close, we in the Deloitte healthcare practice have decided to take stock and reflect on some of the key challenges facing NHS organisations as they come together to form Integrated Care Systems (ICSs). We have asked senior colleagues from across the firm to highlight the burning questions they are being asked about most frequently – and more importantly, what advice they provide.
By Matthew Thaxter, Analyst, Centre for Health Solutions
Each year, the World Health Organization (WHO) holds its ‘World No Tobacco Day’ on May 31. Its goal is to raise awareness on the harmful and deadly effects of tobacco use and second hand smoke exposure, and to discourage the use of tobacco in any form.1 This blog explores some of the latest data on smoking prevalence in the UK, the achievements in reducing the prevalence of smoking and impact that smoking is having on the health of the UK population, the NHS and the wider economy.
By Elizabeth Hampson, Director, Monitor Deloitte
Last week was Mental Health Awareness Week (MHAW), organised by the Mental Health Foundation which, since 2000, has organised its annual campaign around a specific topic. These campaigns have helped raise public awareness of issues such as loneliness, anger, fear and friendship. I have been a passionate advocate for raising awareness of mental health and wellbeing issues for a number of years and wanted to use this opportunity to highlight some of the key initiatives from last week and also explain a little about what Deloitte is doing.